Heart Failure in Pregnancy

Slides:



Advertisements
Similar presentations
 Heart failure is a complex clinical syndrome Can result from:  structural or functional cardiac disorder  impairs the ability of the ventricle to.
Advertisements

HEART DISEASE IN PREGNANCY A.MALIBARY, M.D. Associate Professor
PHYSIOLOGICAL CHANGES IN PREGNANCY AND CONGENITAL HEART DISEASE COMPLICATING PREGNANCY.
Heart Failure in Pregnancy
Mitral Stenosis. Etiology Most cases of mitral stenosis are due to rheumatic fever The rheumatic process causes immobility and thickening of the mitral.
Drugs for Dysrhythmias 19. Learning Outcomes 1. Explain how rhythm abnormalities can affect cardiac function. 2. Illustrate the flow of electrical impulses.
CVS Changes During Pregnancy PARAMETERDIRECTIONTIME COURSE Heart rate ↑ 1 st and 2 nd trimester (TM) Blood pressure ↓ Fall in TM 1 and 2, returns to baseline.
Congestive Heart Failure Stephen Gottlieb, MD Professor of Medicine Director, Cardiomyopathy and Pulmonary Hypertension University of Maryland.
Prepared by : Nehad J. Ahmed.  Heart failure, also known as congestive heart failure (CHF), means your heart can't pump enough blood to meet your body's.
DR. HANA OMER CONGENITAL HEART DEFECTS. The major development of the fetal heart occurs between the fourth and seventh weeks of gestation, and most congenital.
NURSING CARE OF THE CHILD WITH A CARDIOVASCULAR DISEASE
Cardiac Disease in Pregnancy. Physiological Changes in the Cardiovascular System During Pregnancy A thorough knowledge –essential In order to understand.
Dean Handimulya UIEU 2005 Congestive Heart Failure Dean Handimulya, M.D.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 40 Nursing Care of the Child with a Cardiovascular Disorder.
CONGENITAL DISEASES Dr. Meg-angela Christi Amores.
Congenital Heart Disease Emad Al Khatib, RN,MSN,CNS.
PREGNANCY AND HEART FAILURE PROF.DR. MUHAMMAD AKBAR CHAUDHARY M.R.C.P. (U.K.) F.R.C.P. (E) F.R.C.P. (LONDON) F.A.C.C Designed At A.V. Dept. F.J.M.C. By.
Outline The critical physiological changes of pregnancy. The critical physiological changes of pregnancy. Predictors of cardiac events during pregnancy.
Duchenne Muscular Dystrophy: Cardiac Management. Introduction Aim: early detection and treatment of deterioration in heart muscle function Cardiac disease.
Valvular Heart DISEASE
Max Brinsmead MB BS PhD May  In the UK this has increased over time  Deaths in 1982 – per million births  in 2003 – per million.
INTRODUCTION The Normal Heart has four chambers. Consisting of the 2 basic circulation; The pulmonary circulation carrying the deoxygenated blood and.
CARDIAC DISEASES IN PREGNANCY DR. RAZAQ MASHA,FRCOG Assistant Professor & Consultant Department of Obstetrics & Gynaecology.
Cardiac Disease in Pregnancy
Causes of valve disease Valve regurgitation * Congenital *Acute rheumatic carditis *Chronic rhe. Carditis * I E *Syphlitic aortitis *Dilated Valve.
PHYSIOLOGICAL CHANGES IN PREGNANCY AND CONGENITAL HEART DISEASE COMPLICATING PREGNANCY.
CARDIAC DISEASE IN PREGNANCY. Physiologic Changes of Pregnancy Blood volume and cardiac output rise in pregnancy to a peak that is 150% of normal by 24.
Congenital Heart Disease in Children Dr. Sara Mitchell January
Formation of the Heart and Heart Defects Michele Kondracki
Vanessa Beretta & Dan Fleming. About CHD A congenital heart defect also known as CHD is a defect in the structure of the heart and great vessels. Most.
Medical Disease in Pregnancy Cardiovascular Disease Cullen Archer, MD Department of Obstetrics and Gynecology.
Chapter 16 Assessment of Hemodynamic Pressures
HEART DISEASE IN PREGNANCY. The incidence of cardiac lesion is less than 1% among hospital deliveries. The commonest cardiac lesion is of rheumatic origin.
Nursing and heart failure
Adult Medical-Surgical Nursing
Cardiovascular disease in pregnancy Cardiovascular disease in pregnancy Dr.Z Allameh MD.
SHORTNESS OF BREATH IN PREGNANCY. Physiology The normal value for PaO2 in pregnancy is 100 mmHg and for PaCO2 is mmHg. The increased maternal PaO2.
NURSING CARE OF THE CHILD WITH A CARDIOVASCULAR DISEASE Clinical Aspect of Maternal and Child Nursing NUR 363 Lecture 9.
Preterm Birth Hazem Al-Mandeel, M.D Course 481 Obstetrics and Gynecology Rotation.
Management of Heart Disease in Pregnancy.  It is estimated that 1% to 3% of women either have cardiac disease entering pregnancy or are diagnosed with.
Bell Ringer What are Three adaptations for the fetal circulations?
Heart Disease In Pregnancy
Chapter 9 Heart. Review of Structure and Function The heart is divided into the systemic (left) and pulmonary (right) systems –The pulmonary system has.
CONGENITAL HEART DEFECTS DR. HANA OMER. CONGENITAL HEART DEFECTS D. HANA OMER.
Heart disease & pregnancy Dr Movahedi Clinical indicators of Hear disease & pregnancy.
The Child with a Cardiovascular Disorder
– Dr. J. Satish Kumar, MD, Department of Basic & Medical Sciences, AUST General Medicine CVS Name:________________________________________ Congestive Heart.
HARVEY®Simulation Exam VCU Internal Medicine M3 Clerkship IMSPE Exam.
Internal Medicine Workshop Series Laos September /October 2009
Lecture II Congenital Heart Diseases Dr. Aya M. Serry 2015/2016.
CONGENITAL HEART DISEASES
Antithrombotic therapy  -The hypercoagulable state in pregnancy increases  -the risk of thromboembolic disease in women who have :  1arrhythmias  2-
Cardiac diseases in pregnancy. These women should be fully assessed before pregnancy and the maternal and fetal risks carefully explained. Cardiologist.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
HEART DISEASE IN PREGNANCY. Mortality associated with specific cardiac lesions 1. Low risk of maternal mortality (less than 1%). (a) Septal defects. (b)
Congenital Heart Disease
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pregnancy in Patients With Pre-Existing Cardiomyopathies.
Cardiovascular Disease In Pregnancy It is a relatively common in women of child bearing age, complicate about 1% of pregnancies Maternal mortality related.
Akram Sardari.MD Fellowship Of Echocardiography Imam Khomeini Hospital VALVULAR DISEASE IN PREGNANCY.
Heart Disease with Pregnancy
The Pregnant Woman with Cardiac Disease
The cardiovascular system
Congenital Heart Disease
pregnancy in Heart disease
Congestive heart failure
Heart disease with pregnancy
MEDICAL ILLNESS COMPLICATING PREGNANCY
Congenital/Mitral Valve Prolapse
Khalid AlHabib Professor of Cardiac Sciences Cardiology Consultant
Presentation transcript:

Heart Failure in Pregnancy Ramon M. Gonzalez, MD Professor UST Medicine and Surgery

AB a 22y/o married, bank teller Visited for the 1st time an obstetrician 5 months PTC she had a (+) pregnancy test Felt perfectly well prior to consult Few days ago started to have shortness of breath on climbing 2 flights of stairs, easy fatigability on walking 2 blocks and had palpitations

Bp-100/60mmHg CR-89/min RR=21cycles/min Heart- AB at 5th ICS LMCL, no thrills, regular rhythm, loud S1, Grade 3/6 mid-diastolic rumbling murmur at the apex Referred by the obstetrician to a cardiologist

Cardiovascular changes in pregnancy Parameter Percentage of change _______________________________________________ Cardiac output 40-50% Increase Intravascular volume 45% Increase Heart rate 15-25% Increase Systemic vascular resistance 20% Decrease Stroke volume 30% Increase Systolic BP Minimal Diastolic BP 20% Decrease at mid-pregnancy O2 consumption 30-40% Increase

Periods of increase cardiac output 28-32 weeks gestation Labor and Delivery Immediately postpartum

Hemodynamics during labor Parameter Stage of Labor Percentage of change ____________________________________________________ Cardiac output Latent phase 10% Increase Active phase 25% Increase Expulsive phase 40% Increase Immediate postpartum 70-80% Increase Heart rate All stages Increase CVP All stages Increase

Hemodynamics during puerperium Parameter Postpartum Percentage of change _______________________________________________________________ Cardiac output W/in 1hr 30% above pre-labor values 24-48 hr Just below pre-labor values 2 weeks 10% above pre-pregnant values 12-24 weeks Baseline pre-pregnancy values Heart rate Immediate Decrease 2 weeks Pre-pregnant values Stroke volume 48 hr Remains above pre-labor values 24 weeks 10% above pre-pregnant values

What is the effect of pregnancy on heart disease?

Change in New York Heart Association (NYHA) functional class between first visit and follow-up during pregnancy in patients with predominant mitral valve disease.

Maternal outcome in patients with mitral stenosis Congestive heart failure 43% vs 0% p<0.0001 Arrhythmias 20% vs 0% p<0.0001 Hospitalization 43% vs 2 p 0.001 Mortality 0% vs 0% p 1.0

Conclusion Women with VHD had a high rate of clinical deterioration Marked increase in morbid events during pregnancy, including CHF, arrhythmias and need to either initiate or increase cardiovascular drug therapy or to hospitalize patients during pregnancy.

What is the effect of heart disease on fetal outcome?

Fetal outcome in patients with mitral stenosis Preterm delivery 35±7 vs 39±2wks p <0.0002 IUGR 24% vs 0% p <0.001 Stillbirth 4% vs 0% p 0.5 Birth weight 2845g vs 3372g p 0.02

Offspring risk for congenital heart defects Defect Mother affected Father affected (%) (%) Aortic stenosis 13–18 3 Atrial septal defect 4–4.5 1.5 Atrioventricular canal 14 1 Coarctation of the aorta 4 2 Patent ductus arteriosus 3.5–4 2.5 Pulmonic stenosis 4–6.5 2 Tetralogy of Fallot 2.5 1.5 Ventricular septal defect 6–10 2

Main Aims of Management To optimize the mother’s condition during pregnancy To monitor for deteriorations Minimize any additional load on the cardiovascular system

Management of Cardiac Disease in Pregnancy: General Principles of Management Women in NYHA class I and II proceed to pregnancy without morbidity. All women with heart disease should be managed by a multidisciplinary team. Antenatal management is directed towards avoiding cardiac decompensation. Special attention should be directed toward both prevention and early recognition of heart failure.

Warning signs of heart failure Persistent basilar rales, frequently accompanied by a nocturnal cough A sudden diminution in ability to carry out usual duties Increasing dyspnea on exertion Clinical findings may include hemoptysis, progressive edema and tachycardia

Management of Cardiac Disease in Pregnancy: General Principles of Management Even when pregnancy is well tolerated, infection, anemia, pain and anxiety, often result in clinical deterioration and require aggressive management. A clear plan for the management of labor and delivery should be established in advance

Management during Pregnancy In symptomatic patients, medical treatment should be the first line of management. Cardiac drugs commonly used during pregnancy includes β blockers, hydralazine, diuretics and digoxin. Advice bed rest and oxygen.

Management during Pregnancy Fetal assessment to monitor the potential problems arising from heart disease and pharmacologic treatment of the mother.

Management: Labor and Delivery Vaginal delivery is the preferred mode of delivery A short and pain free labor and delivery - minimize hemodynamic fluctuation Hemodynamic monitoring including O2 saturation, ECG, arterial pressure, pulmonary artery and wedge pressures and cardiac output especially in class III and IV patients

Management: Labor and Delivery Epidural analgesia produces good analgesia without major hemodynamic changes It is administered in incremental doses Slower onset of anesthesia, allows maternal CVS to compensate for occurrence of sympathetic blockade, resulting in lower risk of hypotension and decreased uteroplacental blood flow.

Management: Labor and Delivery Epidural analgesia spares the lower extremity “muscle pump,” aiding in venous return and also decreases the incidence of thromboembolic events. During the 2nd stage – prevent maternal effort in “pushing” Shorten the 2nd stage – vacuum or forceps delivery

Management: Labor and Delivery Fetal heart rate monitoring during labor Induction of labor to optimize the timing of delivery in relation to anticoagulation and availability of medical staff Cesarean section obstetrics indication, specific cardiac lesions and deterioration of cardiac performance

Management: Postpartum Oxytocin administered by infusion and not by bolus Methyergonovine and Carboprost Produces severe hypertension, tachycardia and increased pulmonary vascular resistance

Management: Postpartum High level maternal surveillance is required until the main hemodynamic changes after delivery have resolved. Postpartum hemorrhage, infection, anemia and thromboembolism are much more serious complications in those with heart disease.

Management: Postpartum Recent review of parturients with heart disease found that the worst cardiac compromise did not always occur at the time of delivery.

Thank You